Fitness tips, updates, and insights from the Motion team.
Wegovy is the only GLP-1 drug approved for both weight loss and cardiovascular risk reduction. That dual purpose changes how to think about exercise during treatment. Here's what the trial data says.
Read more →
Semaglutide has a lean mass problem that tirzepatide doesn't. About 45% of weight lost in the STEP-1 trial was lean mass, not fat. Here's how to exercise on Ozempic in a way that actually addresses that.
Read more →
Mounjaro works differently to other weight loss drugs, and your approach to exercise should reflect that. Here's what the SURMOUNT trial data says about muscle preservation, and practical tips built around the tirzepatide experience.
Read more →
Most fitness apps weren't designed for GLP-1 users. Here's what features actually help when you're dealing with nausea, shifting energy, and a body that's changing fast.
Read more →
Semaglutide changes what your body needs from exercise. The workouts that serve you best on Ozempic or Wegovy aren't the ones most people start with. Here's what the research actually recommends.
Read more →
GLP-1 medications can do remarkable things. But the research is clear: the people who keep the weight off are the ones who build habits alongside the medication, not instead of it.
Read more →
Weight loss drugs like Ozempic work. But without exercise, a surprising amount of what you lose isn't fat. Here's what the research says, and what to do about it.
Read more →
Most fitness apps weren't designed for moms. Here's what to actually look for — and why it matters more than the feature list.
Read more →
Download Motion free and discover why this is the fitness app you'll actually keep using. Your future self (and your Motmot) will thank you.
